Status:
COMPLETED
Lifestyle Intervention to Treat Diabetes in the Marshall Islands
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
United States Department of Defense
Loma Linda University
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The Republic of the Marshall Islands has the highest prevalence of type 2 diabetes (T2D) in the world. This clinical trial tested whether a community-based, intensive, plant-rich lifestyle interventio...
Eligibility Criteria
Inclusion
- Resident of the Republic of Marshall Islands
- Aged 18 - 75 years
- HbA1c ≥ 8.0% or diagnosed with T2D and taking diabetes medication
- Medical clearance to participate from Diabetes Wellness Center (DWC) physicians.
Exclusion
- Recent (≤3 months) change in a diabetes-related medication dosage
- A physical or medical condition that would impede participation in the lifestyle intervention (e.g., wheel-chair bound, unstable angina)
- Evidence of significant coronary heart disease
- Previous participation in an intensive lifestyle intervention
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2008
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT03862963
Start Date
June 1 2006
End Date
July 31 2008
Last Update
May 16 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.